•There is an association between clinical outcomes and development of cutaneous toxicities due to anticancer therapeutics.•Vitiligo, rash, nail toxicity, or alopecia induced by anticancer therapeutics may be potential biomarkers in predicting treatment efficacy.•Identification of cutaneous toxicities may be an early and non-invasive way to determine cancer treatment efficacy.
Παρασκευή 4 Μαΐου 2018
Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Abstract Multi component tympanometry is not widely used in clinics due lack of evidence supporting its usefulness. The present study was ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.